PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

LOUIS AGNELLO

LOUIS AGNELLO appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Aug 31, 2026

Source-backed chronology

Career Timeline

Dates not reported

Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08

Federal government

Inspect source ↗

Documented career transitions

Revolving Door

Congress → Lobbying

Federal governmentSnr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08McKessonRegistered lobbyist

Federal LDA filings

Lobbying Activity

MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2021

Registrant: AKIN GUMP STRAUSS HAUER & FELD · Health Issues

Issues related to COVID medical response; COVID-19 vaccine distribution; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2021

Registrant: AKIN GUMP STRAUSS HAUER & FELD · Medicare/Medicaid

Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2022

Registrant: AKIN GUMP STRAUSS HAUER & FELD · Health Issues

Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2021

Registrant: AKIN GUMP STRAUSS HAUER & FELD · Health Issues

Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act

LDA filing ↗